MO

MO

USD

Altria Group Inc.

$59.610+0.250 (0.421%)

Цена в режиме реального времени

Consumer Defensive
Табак
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$59.360

Максимум

$59.720

Минимум

$59.050

Объем

1.00M

Фундаментальные показатели компании

Рыночная капитализация

100.4B

Отрасль

Табак

Страна

United States

Статистические данные торговли

Средний объем

10.23M

Биржа

NYQ

Валюта

USD

52-недельный диапазон

Минимум $43.44Текущая $59.610Максимум $60.18

Отчет об анализе ИИ

Последнее обновление: 3 мая 2025 г.
Сгенерировано ИИИсточник данных: Yahoo Finance, Bloomberg, SEC

MO (Altria Group Inc.): What's Happening and What to Watch

Stock Symbol: MO Generate Date: 2025-05-03 00:26:09

Alright, let's break down what's been going on with Altria Group, the company behind brands like Marlboro. We've got a mix of news, some price movement data, and a peek at what an AI model thinks might happen next.

The Recent News Buzz

Looking at the headlines from the past couple of weeks, the picture is definitely mixed.

On the positive side, Altria actually beat its first-quarter profit estimates. That's usually a good sign, showing the core business is performing well on the bottom line.

However, there's a big shadow hanging over that: the company flagged a massive $873 million hit related to its e-cigarette business, NJOY. Shipments for NJOY apparently tanked by a huge 70% because of a patent fight. This is a major negative, as e-cigarettes are supposed to be a key part of Altria's future beyond traditional tobacco.

We also saw a bunch of analyst updates. Here's the interesting part: while their overall ratings vary quite a bit – from "Sell" (UBS) and "Underweight" (Barclays) to "Neutral" (Citigroup) and "Buy" (Stifel) – every single one of them actually raised their price target for the stock. That's a curious signal. It suggests that even analysts who aren't super bullish on the stock overall see some reason for the price to potentially move higher from where their previous targets were. The new targets range from $47 to $63.

Adding another layer of uncertainty, a law firm called Pomerantz has announced they're investigating claims on behalf of investors. This often happens when there's a significant event like the NJOY impairment, looking into whether the company handled things properly. It's not a judgment yet, but it's something to be aware of.

So, the vibe from the news is a bit like a tug-of-war: good on core profit, bad on the NJOY future, mixed signals from analysts (but with raised targets), and a potential legal headache brewing.

Checking the Price Action

Now, let's look at what the stock price itself has been doing over the last month or two.

If you glance at the historical data, you can see the stock has generally been on an upward climb since early March. It started that month in the mid-$50s and has worked its way up. There was a noticeable dip around the beginning of April, but it bounced back pretty quickly.

Recently, the price has been hovering right near its 52-week high of $60.18. The last recorded close was $59.61. So, it's sitting at a pretty elevated level compared to the past year.

What about the AI's crystal ball? The prediction model is calling for small positive moves over the next few days: up about 0.37% today, 0.32% tomorrow, and 0.14% the day after. These are modest increases, suggesting the AI sees a little more room to nudge higher in the very short term, aligning somewhat with the recent upward trend and the fact that analysts raised targets.

Putting It All Together: Outlook & Ideas

Okay, let's try to make sense of this picture.

Based on the mixed news, the stock sitting near its 52-week high, and the AI predicting only small near-term gains, the situation seems to lean towards a "watchful" or "hold" stance right now. It's not a screaming "buy" signal given the NJOY problems and legal investigation, even though core earnings were good and analysts raised targets. The price is already quite high.

Here's how you might think about potential moves, keeping in mind this is just analysis based on the data, not financial advice:

  • If you're thinking about buying: The price is high right now. A potential strategy might be to wait for a pullback. If the stock dips back towards a recent support level – maybe around the high $58s or low $59s where it traded before the recent push higher – that could be a more interesting entry point than buying right at the 52-week high. The AI's short-term predictions are positive but small, not suggesting a huge breakout is imminent based solely on that.
  • If you already own the stock: With the price near the 52-week high, you might consider setting a stop-loss to protect your gains. A logical place could be just below a recent low or support level, perhaps around the $58.50 mark or even lower depending on your risk tolerance. This helps limit potential losses if the mixed news or legal issues cause the stock to drop. For taking profits, you could look slightly above the 52-week high if the AI's predicted upward trend continues, or consider the lower end of the raised analyst targets as a longer-term goal, though those are less immediate.

Remember, the recommendation data also points to a low P/E ratio compared to the industry, which can suggest it's undervalued (as the "Undervalued Gem" tag notes), but this is countered by negative revenue growth and the NJOY issues. Technicals like MACD and OBV look positive, suggesting recent buying pressure, but DMI shows a bearish trend – conflicting signals there too. The overall recommendation score is just slightly above neutral (55.42).

A Little Company Context

It's important to remember that Altria is primarily a tobacco company. It falls under the "Consumer Defensive" sector, meaning its products are often bought regardless of the economic climate. However, the big challenge for these companies is the long-term decline in smoking. That's why their efforts in areas like e-cigarettes (like NJOY) are so crucial for future growth. The significant problems with NJOY highlighted in the news are therefore a pretty big deal for the company's strategy moving forward.


Disclaimer: This report is an analysis based on the provided data and should not be considered financial advice. Stock markets are volatile, and investing involves risk. Always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Связанные новости

Analyst Upgrades

Barclays Maintains Underweight on Altria Group, Raises Price Target to $49

Barclays analyst Gaurav Jain maintains Altria Group with a Underweight and raises the price target from $46 to $49.

Просмотреть больше
Barclays Maintains Underweight on Altria Group, Raises Price Target to $49
Analyst Upgrades

Stifel Maintains Buy on Altria Group, Raises Price Target to $63

Stifel analyst Matthew Smith maintains Altria Group with a Buy and raises the price target from $60 to $63.

Просмотреть больше
Stifel Maintains Buy on Altria Group, Raises Price Target to $63
Analyst Upgrades

UBS Maintains Sell on Altria Group, Raises Price Target to $47

UBS analyst Faham Baig maintains Altria Group with a Sell and raises the price target from $46 to $47.

Просмотреть больше
UBS Maintains Sell on Altria Group, Raises Price Target to $47
Reuters

Altria tops quarterly profit estimates, flags $873 million NJOY impairment

Tobacco company Altria on Tuesday beat first-quarter profit estimates but flagged an $873 million impairment at its e-cigarette business, where shipments dropped 70% amid a patent dispute.

Просмотреть больше
Altria tops quarterly profit estimates, flags $873 million NJOY impairment
PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altria Group, Inc. - MO

Pomerantz LLP is investigating claims on behalf of investors of Altria Group, Inc. ("Altria" or the "Company") (NYSE: MO). Such investors are advised ...

Просмотреть больше
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altria Group, Inc. - MO
Analyst Upgrades

Citigroup Maintains Neutral on Altria Group, Raises Price Target to $55

Citigroup analyst Adam Spielman maintains Altria Group with a Neutral and raises the price target from $52 to $55.

PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altria Group, Inc. - MO

Pomerantz LLP is investigating claims on behalf of investors of Altria Group, Inc. ("Altria" or the "Company") (NYSE: MO). Such investors are advised ...

Прогноз ИИBeta

Рекомендация ИИ

Бычий

Обновлено в: 3 мая 2025 г., 04:46

МедвежийНейтральныйБычий

67.2% Уверенность

Риск и торговля

Уровень риска1/5
Низкий риск
Подходит для
СтоимостьКонсервативный
Руководство по торговле

Точка входа

$59.42

Взять прибыль

$62.48

Остановить убытки

$53.64

Ключевые факторы

PDI 4.0 выше MDI 2.7 с ADX 23.3, что предполагает бычий тренд
Текущая цена очень близка к уровню поддержки ($59.50), что предполагает сильную возможность покупки
Объем торгов в 6.1 раз превышает среднее значение (112,669), что указывает на чрезвычайно сильное покупательское давление
MACD 0.0570 выше сигнальной линии 0.0564, что указывает на бычье пересечение

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.